Department of Medicine

Study compares kidney injury risk for COVID, flu patients

A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza.

Talbot named to infection prevention society’s leadership

Vanderbilt’s Tom Talbot, MD, MPH, was recently elected to serve in the leadership of the Society for Healthcare Epidemiology of America.

José Ontiveros, center, and his wife, Isela Morales, to his left, are surrounded by some of the team members who helped save his life as he battled post-COVID complications, including from left, infectious disease specialist Karen Bloch, MD, MPH; interpreter Eleazar Jimenez; orthopaedic surgeon Amir Abtahi, MD; infectious disease specialist Christina Fiske, MD, MPH; and otolaryngologist Sarah Rohde, MD, MMHC.

Teamwork returns man with severe post-COVID complications to his life

A multidisciplinary team at Vanderbilt helped José Ontiveros cope with a long list of severe complications arising from his COVID-19i infection.

Microbiome reflects COVID-19 severity

Characterization of the upper respiratory tract microbiome could help predict outcomes for COVID-19 infection, Vanderbilt researchers have discovered.

Bots boost liver cancer outcome

Vanderbilt researchers report that robotic-assisted surgery is comparable, if not superior, to laparoscopic surgery for early-stage liver cancer patients.

ICU study confirms safety of delabeling penicillin allergies

A Vanderbilt study shows that physicians can safely identify and disprove low-risk penicillin allergies using an oral amoxicillin challenge in consenting patients, even those in the intensive care unit who are recovering from critical illness.

1 47 48 49 50 51 125